Obstetrical & gynecological survey · 2025
Diagnosis and Management of Acute Venous Thromboembolism in Pregnancy and the Puerperium: A Comprehensive Review of Guidelines.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Boureka Eirini, Ralli Elpiniki-Elpida, Arvanitaki Alexandra, Lefkou Eleftheria, Fragakis Nikolaos, Giannakoulas George, Mamopoulos Apostolos, Dagklis Themistoklis, Tsakiridis Ioannis
Аннотация
IMPORTANCE: Venous thromboembolism (VTE) manifesting either as deep vein thrombosis or pulmonary embolism presents as the leading cause of maternal morbidity and mortality, worldwide.
OBJECTIVE: The aim of this study was to review and compare the most recently published international guidelines on the diagnosis and management of acute VTE in pregnancy and the puerperium.
EVIDENCE ACQUISITION: A comparative review of guidelines by the American College of Obstetricians and Gynecologists, the Royal College of Obstetricians and Gynecologists, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, the Society of Obstetricians and Gynecologists of Canada, the American College of Chest Physicians, the European Society of Cardiology, and the American Society of Hematology on VTE was conducted.
RESULTS: There is a consensus among the reviewed guidelines regarding the appropriate algorithm for diagnosis of VTE in the obstetric population, the appropriate anticoagulants suitable for the pregnancy and puerperium, even in cases of contraindications for heparin, and indications for extreme management measures, such as thrombolysis. On the other hand, few discrepancies were detected on the dosage of anticoagulants, indications of anticoagulation monitoring, appropriate management of anticoagulants related to neuraxial anesthesia, and indications for thrombophilia testing following a VTE event. Notably, only the European Society of Cardiology recommends the use of models assessing the clinical likelihood of pulmonary embolism, suggests a risk stratification algorithm to guide acute management, and proposes management strategies for the prevention of hemorrhagic events during labor.
CONCLUSIONS: VTE is a significant contributor of maternal morbidity and mortality, especially if managed in a suboptimal way. Hence, the development of consistent evidence-based protocols and algorithms is crucial to safely guide pregnant women and their physicians toward reducing improving fetal and maternal outcomes.
OBJECTIVE: The aim of this study was to review and compare the most recently published international guidelines on the diagnosis and management of acute VTE in pregnancy and the puerperium.
EVIDENCE ACQUISITION: A comparative review of guidelines by the American College of Obstetricians and Gynecologists, the Royal College of Obstetricians and Gynecologists, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, the Society of Obstetricians and Gynecologists of Canada, the American College of Chest Physicians, the European Society of Cardiology, and the American Society of Hematology on VTE was conducted.
RESULTS: There is a consensus among the reviewed guidelines regarding the appropriate algorithm for diagnosis of VTE in the obstetric population, the appropriate anticoagulants suitable for the pregnancy and puerperium, even in cases of contraindications for heparin, and indications for extreme management measures, such as thrombolysis. On the other hand, few discrepancies were detected on the dosage of anticoagulants, indications of anticoagulation monitoring, appropriate management of anticoagulants related to neuraxial anesthesia, and indications for thrombophilia testing following a VTE event. Notably, only the European Society of Cardiology recommends the use of models assessing the clinical likelihood of pulmonary embolism, suggests a risk stratification algorithm to guide acute management, and proposes management strategies for the prevention of hemorrhagic events during labor.
CONCLUSIONS: VTE is a significant contributor of maternal morbidity and mortality, especially if managed in a suboptimal way. Hence, the development of consistent evidence-based protocols and algorithms is crucial to safely guide pregnant women and their physicians toward reducing improving fetal and maternal outcomes.